Source: SEBI
As disclosed by the issuer.
| KPI | Value | Period | Pages |
|---|---|---|---|
| RoNW for March 31, 2026 | 4.55% | March 31, 2026 | — |
| NAV per Equity Share as on March 31, 2026 | ₹116.96 | March 31, 2026 | — |
AGS Health Limited is a leading provider of technology-driven Revenue Cycle Management (RCM) solutions, primarily serving U.S. healthcare providers. The company leverages AI and data analytics to enhance operational efficiency and has established a strong customer base, including major health systems and hospitals. As of March 31, 2026, AGS served 82 health systems/hospital customers, with over 90% of its revenue derived from direct provider relationships.
The U.S. healthcare market is projected to grow significantly, with national health expenditure expected to rise from approximately USD 4.4 trillion in CY 2021 to USD 7.4 trillion by CY 2030. The aging population and increasing chronic disease burden are key drivers of healthcare demand, creating substantial opportunities for RCM providers like AGS Health Limited.